Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of September 20, 2026, XLO trades at $9.17 with a market cap of $60.08M and a P/E ratio of -1.93. XLO moved +0.00% today. Year to date, XLO is +1.87%; over the trailing twelve months it is -14.57%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $9.17 |
| Market Cap | $60.08M |
| P/E Ratio | -1.93 |
| EPS | $-4.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.80 |
| 52-Week Low | $6.47 |
| Volume | 11.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $64.09M |
| Net Income | $-21.83M |
| Gross Margin | 0.00% |
XLO analyst coverage data. Average price target: $0.00.